4D Molecular Therapeutics Inc
NASDAQ:FDMT
Intrinsic Value
The intrinsic value of one
FDMT
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 9.49 USD,
4D Molecular Therapeutics Inc
is
hidden
.
Valuation History
4D Molecular Therapeutics Inc
FDMT looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether FDMT usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for 4D Molecular Therapeutics Inc.
Fundamental Analysis
FDMT Profitability Score
Profitability Due Diligence
Score
FDMT Solvency Score
Solvency Due Diligence
Score
Balance Sheet Decomposition
4D Molecular Therapeutics Inc
4D Molecular Therapeutics Inc
Free Cash Flow Analysis
4D Molecular Therapeutics Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
4D Molecular Therapeutics Inc
Wall St
Price Targets
FDMT Price Targets Summary
4D Molecular Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
FDMT
is 33.77 USD
with a low forecast of 17.17 USD and a high forecast of 47.25 USD.
Dividends
Current shareholder yield for
FDMT is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
FDMT
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 9.49 USD,
4D Molecular Therapeutics Inc
is
hidden
.